The University of Miami received a transformational $50-million gift from Kenneth C. Griffin, founder and CEO of Citadel and founder of Griffin Catalyst, to Sylvester Comprehensive Cancer Center, part of the University of Miami Health System and the Miller School of Medicine.
The gift will double the center’s research footprint, accelerating efforts to develop new therapies, enhancing care for patients, and expanding access to clinical trials in a new 12-story, 244,000-square-foot facility set to open in 2025. The new facility will be named the Kenneth C. Griffin Cancer Research Building.
The new building comes as Sylvester — one of 72 cancer centers nationwide to hold the distinction —renews its coveted NCI status. Its design will advance innovative research to develop new therapies and expand ongoing clinical trials. Read the full story at news.miami.edu.
